Cargando…

Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies

In patients with dysfunctions of the Ca(2+) channel ORAI1, stromal interaction molecule 1 (STIM1) or integrin-regulating kindlin-3 (FERMT3), severe immunodeficiency is frequently linked to abnormal platelet activity. In this paper, we studied platelet responsiveness by multiparameter assessment of w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagy, Magdolna, Mastenbroek, Tom G., Mattheij, Nadine J.A., de Witt, Susanne, Clemetson, Kenneth J., Kirschner, Janbernd, Schulz, Ansgar S., Vraetz, Thomas, Speckmann, Carsten, Braun, Attila, Cosemans, Judith M.E.M., Zieger, Barbara, Heemskerk, Johan W.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ferrata Storti Foundation 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830379/
https://www.ncbi.nlm.nih.gov/pubmed/29242293
http://dx.doi.org/10.3324/haematol.2017.176974
_version_ 1783302986586390528
author Nagy, Magdolna
Mastenbroek, Tom G.
Mattheij, Nadine J.A.
de Witt, Susanne
Clemetson, Kenneth J.
Kirschner, Janbernd
Schulz, Ansgar S.
Vraetz, Thomas
Speckmann, Carsten
Braun, Attila
Cosemans, Judith M.E.M.
Zieger, Barbara
Heemskerk, Johan W.M.
author_facet Nagy, Magdolna
Mastenbroek, Tom G.
Mattheij, Nadine J.A.
de Witt, Susanne
Clemetson, Kenneth J.
Kirschner, Janbernd
Schulz, Ansgar S.
Vraetz, Thomas
Speckmann, Carsten
Braun, Attila
Cosemans, Judith M.E.M.
Zieger, Barbara
Heemskerk, Johan W.M.
author_sort Nagy, Magdolna
collection PubMed
description In patients with dysfunctions of the Ca(2+) channel ORAI1, stromal interaction molecule 1 (STIM1) or integrin-regulating kindlin-3 (FERMT3), severe immunodeficiency is frequently linked to abnormal platelet activity. In this paper, we studied platelet responsiveness by multiparameter assessment of whole blood thrombus formation under high-shear flow conditions in 9 patients, including relatives, with confirmed rare genetic mutations of ORAI1, STIM1 or FERMT3. In platelets isolated from 5 out of 6 patients with ORAI1 or STIM1 mutations, store-operated Ca(2+) entry (SOCE) was either completely or partially defective compared to control platelets. Parameters of platelet adhesion and aggregation on collagen microspots were impaired for 4 out of 6 patients, in part related to a low platelet count. For 4 patients, platelet adhesion/aggregation and procoagulant activity on von Willebrand Factor (VWF)/rhodocytin and VWF/fibrinogen microspots were impaired independently of platelet count, and were partly correlated with SOCE deficiency. Measurement of thrombus formation at low shear rate confirmed a greater impairment of platelet functionality in the ORAI1 patients than in the STIM1 patient. For 3 patients/relatives with a FERMT3 mutation, all parameters of thrombus formation were strongly reduced regardless of the microspot. Bone marrow transplantation, required by 2 patients, resulted in overall improvement of platelet function. We concluded that multiparameter assessment of whole blood thrombus formation in a surface-dependent way can detect: i) additive effects of low platelet count and impaired platelet functionality; ii) aberrant ORAI1-mediated Ca(2+) entry; iii) differences in platelet activation between patients carrying the same ORAI1 mutation; iv) severe platelet function impairment linked to a FERMT3 mutation and bleeding history.
format Online
Article
Text
id pubmed-5830379
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Ferrata Storti Foundation
record_format MEDLINE/PubMed
spelling pubmed-58303792018-03-16 Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies Nagy, Magdolna Mastenbroek, Tom G. Mattheij, Nadine J.A. de Witt, Susanne Clemetson, Kenneth J. Kirschner, Janbernd Schulz, Ansgar S. Vraetz, Thomas Speckmann, Carsten Braun, Attila Cosemans, Judith M.E.M. Zieger, Barbara Heemskerk, Johan W.M. Haematologica Article In patients with dysfunctions of the Ca(2+) channel ORAI1, stromal interaction molecule 1 (STIM1) or integrin-regulating kindlin-3 (FERMT3), severe immunodeficiency is frequently linked to abnormal platelet activity. In this paper, we studied platelet responsiveness by multiparameter assessment of whole blood thrombus formation under high-shear flow conditions in 9 patients, including relatives, with confirmed rare genetic mutations of ORAI1, STIM1 or FERMT3. In platelets isolated from 5 out of 6 patients with ORAI1 or STIM1 mutations, store-operated Ca(2+) entry (SOCE) was either completely or partially defective compared to control platelets. Parameters of platelet adhesion and aggregation on collagen microspots were impaired for 4 out of 6 patients, in part related to a low platelet count. For 4 patients, platelet adhesion/aggregation and procoagulant activity on von Willebrand Factor (VWF)/rhodocytin and VWF/fibrinogen microspots were impaired independently of platelet count, and were partly correlated with SOCE deficiency. Measurement of thrombus formation at low shear rate confirmed a greater impairment of platelet functionality in the ORAI1 patients than in the STIM1 patient. For 3 patients/relatives with a FERMT3 mutation, all parameters of thrombus formation were strongly reduced regardless of the microspot. Bone marrow transplantation, required by 2 patients, resulted in overall improvement of platelet function. We concluded that multiparameter assessment of whole blood thrombus formation in a surface-dependent way can detect: i) additive effects of low platelet count and impaired platelet functionality; ii) aberrant ORAI1-mediated Ca(2+) entry; iii) differences in platelet activation between patients carrying the same ORAI1 mutation; iv) severe platelet function impairment linked to a FERMT3 mutation and bleeding history. Ferrata Storti Foundation 2018-03 /pmc/articles/PMC5830379/ /pubmed/29242293 http://dx.doi.org/10.3324/haematol.2017.176974 Text en Copyright© 2018 Ferrata Storti Foundation Material published in Haematologica is covered by copyright. All rights are reserved to the Ferrata Storti Foundation. Use of published material is allowed under the following terms and conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode. Copies of published material are allowed for personal or internal use. Sharing published material for non-commercial purposes is subject to the following conditions: https://creativecommons.org/licenses/by-nc/4.0/legalcode, sect. 3. Reproducing and sharing published material for commercial purposes is not allowed without permission in writing from the publisher.
spellingShingle Article
Nagy, Magdolna
Mastenbroek, Tom G.
Mattheij, Nadine J.A.
de Witt, Susanne
Clemetson, Kenneth J.
Kirschner, Janbernd
Schulz, Ansgar S.
Vraetz, Thomas
Speckmann, Carsten
Braun, Attila
Cosemans, Judith M.E.M.
Zieger, Barbara
Heemskerk, Johan W.M.
Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies
title Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies
title_full Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies
title_fullStr Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies
title_full_unstemmed Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies
title_short Variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies
title_sort variable impairment of platelet functions in patients with severe, genetically linked immune deficiencies
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5830379/
https://www.ncbi.nlm.nih.gov/pubmed/29242293
http://dx.doi.org/10.3324/haematol.2017.176974
work_keys_str_mv AT nagymagdolna variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT mastenbroektomg variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT mattheijnadineja variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT dewittsusanne variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT clemetsonkennethj variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT kirschnerjanbernd variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT schulzansgars variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT vraetzthomas variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT speckmanncarsten variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT braunattila variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT cosemansjudithmem variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT ziegerbarbara variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies
AT heemskerkjohanwm variableimpairmentofplateletfunctionsinpatientswithseveregeneticallylinkedimmunedeficiencies